Hycor Biomedical Profits Skyrocket

Hycor Biomedical Inc., the Garden Grove manufacturer of medical and diagnostic products, said its profits more than tripled in the second quarter to $788,000, or 9 cents per share. That compares to net income of $219,000, or 4 cents a share, in the same period a year earlier. Sales in the latest three months rose 139% to $6.8 million, from $2.9 million. For the first half of the year, Hycor posted a $1.6-million profit, compared to $479,000 in 1991. Sales more than doubled, to $13.7 million from $5.6 million. The company’s profits and sales have grown sharply since it bought Ventrex Laboratories Inc. in August.